UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of ~~December~~March ~~2016~~2017

Commission File Number: 333-196065

Parnell Pharmaceuticals Holdings Ltd
(Translation of registrant's name into English)

Unit 4, Century Estate
476 Gardeners Road
Alexandria 2015 NSW
Australia
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ] Form 40-F [ ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

OnNote: Regulation ~~December~~S-T ~~19,~~Rule ~~2016,~~101(b)(7) only permits the ~~Registrant~~submission ~~issued~~in paper of a ~~press~~Form ~~release,~~6-K if submitted to furnish a ~~copy~~report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is ~~attached~~incorporated, ~~hereto~~domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as ~~Exhibit~~long ~~99.1~~as ~~and~~the report or other document is ~~incorporated~~not ~~herein~~a bypress ~~reference.~~release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

On March 21, 2017, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference. (c) Exhibit 99.1. Press release dated ~~December~~March 1921, ~~2016~~2017

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		Parnell Pharmaceuticals Holdings Ltd
		(Registrant)
Date: December 19, 2016		/s/ Robert Joseph
Date: March 21, 2017		/s/ Robert Joseph
		Robert Joseph
		President and CEO

Filing Compare · Parnell Pharmaceuticals Holdings Ltd